Drugs / AKK PROBIO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07593170 | Jun → Dec 2026 expected | obesity disorder | Central South University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AKK PROBIO | “This intervention trial intends to use pasteurized AKK PROBIO, with each dose containing the equivalent of 30 billion inactivated bacterial cells.” NCT07593170 ↗ |
| Modality | Other / unclassified | “The pasteurized AKK PROBIO (belonging to prebiotics) have been proven to have good safety and metabolic improvement effects in adults.” NCT07593170 ↗ |
| Route | Oral | “The subjects take one AKK probiotic capsule orally before each breakfast and dinner every day” NCT07593170 ↗ |